skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: Elsevier ClinicalKey Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Status of vaccine research and development of vaccines for herpes simplex virus
Status of vaccine research and development of vaccines for herpes simplex virus
Material Type:
Artigo 		Adicionar ao Meu Espaço

Status of vaccine research and development of vaccines for herpes simplex virus

Johnston, Christine ; Gottlieb, Sami L. ; Wald, Anna

Vaccine, 2016-06, Vol.34 (26), p.2948-2952 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10–17 years of age: Results from a randomised, controlled, double-blind trial
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10–17 years of age: Results from a randomised, controlled, double-blind trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10–17 years of age: Results from a randomised, controlled, double-blind trial

HENDRIK RICHARDUS, Jan

Vaccine, 2013-12, Vol.31 (51), p.6136-6143 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge
Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge

Morello, Christopher S ; Kraynyak, Kimberly A ; Levinson, Michael S ; Chen, Zhijiang ; Lee, Kuo-Fen ; Spector, Deborah H

Vaccine, 2012-10, Vol.30 (46), p.6541-6550 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial
Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial

Baird, Sarah J, PhD ; Garfein, Richard S, Prof ; McIntosh, Craig T, PhD ; Özler, Berk, Dr

The Lancet (British edition), 2012-04, Vol.379 (9823), p.1320-1329 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Current status and prospects for development of an HSV vaccine
Current status and prospects for development of an HSV vaccine
Material Type:
Artigo 		Adicionar ao Meu Espaço

Current status and prospects for development of an HSV vaccine

Johnston, Christine ; Koelle, David M ; Wald, Anna

Vaccine, 2014-03, Vol.32 (14), p.1553-1560 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Seroepidemiology of herpes simplex virus type 1 and 2 in pregnant women in Switzerland: an obstetric clinic based study
Seroepidemiology of herpes simplex virus type 1 and 2 in pregnant women in Switzerland: an obstetric clinic based study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Seroepidemiology of herpes simplex virus type 1 and 2 in pregnant women in Switzerland: an obstetric clinic based study

Kucera, Pavel ; Gerber, Stefan ; Marques-Vidal, Pedro ; Meylan, Pascal R.A

European journal of obstetrics & gynecology and reproductive biology, 2012-01, Vol.160 (1), p.13-17 [Periódico revisado por pares]

Ireland: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
7
Fulminant gestational hepatitis due to primary herpes simplex type 2 infection: use of serum HSV polymerase chain reaction for noninvasive diagnosis
Fulminant gestational hepatitis due to primary herpes simplex type 2 infection: use of serum HSV polymerase chain reaction for noninvasive diagnosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fulminant gestational hepatitis due to primary herpes simplex type 2 infection: use of serum HSV polymerase chain reaction for noninvasive diagnosis

Nienaber, Ju-Hsien J.C ; McNamara, David R ; Banerjee, Ritu ; Pritt, Bobbi S ; Karre, Tess ; Sohail, Muhammad R

Diagnostic microbiology and infectious disease, 2012-02, Vol.72 (2), p.181-184 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Serologic Screening for Herpes Simplex Virus Type 2 in Persons With Human Immunodeficiency Virus
Serologic Screening for Herpes Simplex Virus Type 2 in Persons With Human Immunodeficiency Virus
Material Type:
Artigo 		Adicionar ao Meu Espaço

Serologic Screening for Herpes Simplex Virus Type 2 in Persons With Human Immunodeficiency Virus

Van Wagoner, Nicholas J., MD, PhD ; Dixon, Paula, MLT ASCP ; Hook, Edward W., MD ; Morrow, Rhoda, PhD ; Lee, Jeannette, PhD

The American journal of the medical sciences, 2013-08, Vol.346 (2), p.108-112 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons
Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons

Wald, Anna ; Koelle, David M ; Fife, Kenneth ; Warren, Terri ; LeClair, Kenneth ; Chicz, Roman M ; Monks, Stephen ; Levey, Daniel L ; Musselli, Cristina ; Srivastava, Pramod K

Vaccine, 2011-11, Vol.29 (47), p.8520-8529 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
Material Type:
Artigo 		Adicionar ao Meu Espaço

Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine

LaTourette, Philip C. ; Awasthi, Sita ; Desmond, Angela ; Pardi, Norbert ; Cohen, Gary H. ; Weissman, Drew ; Friedman, Harvey M.

Vaccine, 2020-11, Vol.38 (47), p.7409-7413 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1987  (37)
  2. 1987Até1995  (61)
  3. 1996Até2004  (111)
  4. 2005Até2014  (182)
  5. Após 2014  (85)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (36)
  2. Espanhol  (1)
  3. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.